Rigel Pharmaceuticals (RIGL) Receivables - Net (2013 - 2026)
Rigel Pharmaceuticals (RIGL) reported Receivables - Net of $56.04 million for Q2 2026, up 40.4% from $39.91 million a year earlier and up 12.2% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Receivables - Net (2013 - 2026) Analysis & Trends
At the end of FY2025, Rigel Pharmaceuticals posted Receivables - Net of $51.76 million, up 24.4% from FY2024.
- Receivables - Net has a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
- By year, Receivables - Net came in at $41.62 million in FY2024 (+36.2%), $30.55 million in FY2023 (-24.2%), $40.32 million in FY2022 (+160.6%) and $15.47 million in FY2021 (-3.1%).
- The Q2 2026 figure ranks as the highest quarterly Receivables - Net since Q1 2021.
- Year over year, Receivables - Net has now increased in each of the last nine quarters, with growth averaging 36.3% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q1 2023 (growth of 92.7%); the low point was Q1 2022 (a decline of 89.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $49.95 million (Q1 2026), $51.76 million (Q4 2025) and $45.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Rigel Pharmaceuticals | 922.04 Mn | 387.93 Mn | 70.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.04 Mn |
| Mar 31, 2026 | 49.95 Mn |
| Dec 31, 2025 | 51.76 Mn |
| Sep 30, 2025 | 45.93 Mn |
| Jun 30, 2025 | 39.91 Mn |
| Mar 31, 2025 | 41.55 Mn |
| Dec 31, 2024 | 41.62 Mn |
| Sep 30, 2024 | 30.58 Mn |
| Jun 30, 2024 | 28.90 Mn |
| Mar 31, 2024 | 27.51 Mn |
| Dec 31, 2023 | 30.55 Mn |
| Sep 30, 2023 | 23.55 Mn |
| Jun 30, 2023 | 20.82 Mn |
| Mar 31, 2023 | 29.37 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 15.53 Mn |
| Jun 30, 2022 | 17.20 Mn |
| Mar 31, 2022 | 15.24 Mn |
| Dec 31, 2021 | 15.47 Mn |
| Sep 30, 2021 | 14.99 Mn |
API Access
Rigel Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();